Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Authors :: Gupta R
Raviglione MC
Espinal MA
Source :: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2001 Dec; Vol. 5 (12), pp. 1078-9.
Publication Year :: 2001

Subjects :: Humans
International Cooperation
Practice Guidelines as Topic
World Health Organization
Antitubercular Agents therapeutic use
Government Programs trends
Isoniazid therapeutic use
National Health Programs trends
Rifampin therapeutic use
Tuberculosis, Multidrug-Resistant drug therapy

Language :: English
ISSN :: 1027-3719
Volume :: 5
Issue :: 12
Database :: MEDLINE
Journal :: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Publication Type :: Academic Journal
Accession number :: 11769764

Tools